{"id":"cd07805-47-gel","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation"},{"rate":null,"effect":"Erythema"},{"rate":null,"effect":"Dryness"},{"rate":null,"effect":"Photosensitivity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a retinoid compound formulated as a gel, CD07805/47 works by binding to retinoid receptors in skin cells, promoting cell turnover and reducing comedone formation. It also exhibits anti-inflammatory properties that help reduce acne-associated inflammation and bacterial colonization on the skin surface.","oneSentence":"CD07805/47 gel is a topical retinoid that modulates skin cell differentiation and reduces inflammation for acne treatment.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:48.078Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"}]},"trialDetails":[{"nctId":"NCT01659853","phase":"PHASE3","title":"Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2012-09","conditions":"Erythema, Rosacea","enrollment":70},{"nctId":"NCT01174030","phase":"PHASE2","title":"Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-08","conditions":"Rosacea","enrollment":269},{"nctId":"NCT01355458","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-05","conditions":"Rosacea","enrollment":260},{"nctId":"NCT01318733","phase":"PHASE3","title":"Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-03","conditions":"Rosacea","enrollment":449},{"nctId":"NCT00989014","phase":"PHASE2","title":"Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-09","conditions":"Erythematotelangiectatic Rosacea","enrollment":122},{"nctId":"NCT02616250","phase":"PHASE4","title":"MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2015-12","conditions":"Rosacea","enrollment":190},{"nctId":"NCT01355471","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-05","conditions":"Rosacea","enrollment":293},{"nctId":"NCT02300129","phase":"PHASE2","title":"Effect of CD07805/47 Gel in Rosacea Flushing","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-04","conditions":"Rosacea","enrollment":34},{"nctId":"NCT01882712","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema","status":"WITHDRAWN","sponsor":"Galderma R&D","startDate":"","conditions":"Erythema","enrollment":""},{"nctId":"NCT01789775","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2012-12","conditions":"Rosacea","enrollment":114}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9646,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CD07805/47 gel","genericName":"CD07805/47 gel","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CD07805/47 gel is a topical retinoid that modulates skin cell differentiation and reduces inflammation for acne treatment. Used for Acne vulgaris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}